Butyrylcholinesterase activity is reduced in haemodialysis patients: Is there association with hyperhomocysteinemia and/or oxidative stress?

Clinical Biochemistry

Volumn 41, Issue 7-8, 2008, Pages 474-479

  Garcia, Solange C ^a   Wyse, Ângela T S ^b   Valentini, Juliana ^a   Roehrs, Miguel ^a   Moro, Angela M ^a   Paniz, Clóvis ^a   Schmitt, Gabriela ^a   Grotto, Denise ^a   Pomblum, Valdeci J ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Blood; Butyrylcholinesterase; Haemodialysis patients; Hyperhomocysteinemia; Oxidative stress biomarkers

Indexed keywords

CHOLINESTERASE; METHEMOGLOBIN; PORPHOBILINOGEN SYNTHASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; MORTALITY; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; AGED; BUTYRYLCHOLINESTERASE; DOWN-REGULATION; ENZYME ACTIVATION; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS;

EID: 41849142982     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.01.005     Document Type: Article

References (55)

1. Darvesh S., Hopkins D.A., and Geula C. Neurobiology of butyrylcholinesterase. Nat Rev Neurosci 17 (2003) 131-138
2. Stedman E., Stedman E., and Easson L.H. Cholinesterase. An enzyme present in the blood-serum of horse. Biochem J 26 (1932) 2056-2066
3. Stefanelo F.M., Franzon R., Tagliari B., et al. Reduction of butyrylcholinesterase activity in rat serum subjected to hyperhomocysteinemia. Metab Brain Dis 20 (2005) 97-103
4. Mesulam M.M., Guillozet A., Shaw P., et al. Acethylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyse acetylcholine. Neuroscience 110 (2002) 627-639
5. Stefanelo F.M., Zugno A.I., Wannmacher C.M.D., et al. Homocysteine inhibits butyrylcholinesterase activity in rat serum. Metab Brain Dis 18 (2003) 187-194
6. Perna A.F., Ingrosso D., Molino D., et al. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients - Italian initiative on uremic hyperhomocysteinemia (IIUH). J Nephrol 16 (2003) 516-521
7. Coen van Guldener M.D., Coen D.A., and Stehouwer M.D. Homocysteine and methionine metabolism in renal failure. Semin Vasc Med 5 (2005) 201-208
8. Anan F., Takahashi N., Shimomura T., et al. Hyperhomocysteinemia is a significant risk factor for silent cerebral infarction in patients with chronic renal failure undergoing haemodialysis. Metabolism 55 (2006) 656-661
9. Fanapour P.C., Yug B., and Kochar M.S. Hyperhomocysteinemia: an additional cardiovascular risk factor. WMJ 98 (1999) 51-54
10. Bechara E.J.H., Medeiros M.H.G., Monteiro H.P., et al. A free radical hypothesis of lead poisoning and inborn porphyries associated with 5-aminolevulinic acid overload. Quim Nova 16 (1993) 385-392
11. Djordjevic V.B., Strahinjic S., Karacevic D., et al. Erythrocyte delta-aminole-vulinate dehydratase measurements in Balkan endemic nephropathy. Kidney Int Suppl 34 (1991) S93-S96.
12. Becaria A., Campbell A., and Bondy S.C. Aluminum as a toxicant. Toxicol Ind Health 18 (2002) 309-320
13. Chmielnicka J., Nasiadek M., and Lewandiwska-Zyndul E. Effect of aluminium on hematopoesis after intraperitoneal exposure in rats. Ecotoxicol Environ Safe 33 (1995) 201-206
14. Deloncle R., Huguet F., Babin P., et al. Chronic administration of aluminum l-glutamate in young mature rats: effects on iron levels and lipid peroxidation in selected brain areas. Toxicol Lett 104 (1999) 65-73
15. Zachée P., Ferrant A., Daelemans R., et al. Oxidative injury to erythrocytes cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment. Nephron 65 (1993) 288-293
16. Fontanellas A., Herrero J.A., Coronel F., et al. Effects of recombinant human erythropoietin on porphyrin metabolism in uremic patients on haemodialysis. J Am Soc Nephrol 7 (1996) 774-779
17. Lucchi L., Cappelli G., Acerbi M.A., et al. Oxidative metabolism of polymorphonuclear leukocytes and serum opsonic activity in chronic renal failure. Nephron 51 (1989) 44-50
18. Ellman G.L., Callaway E., Andres K.D., et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7 (1961) 88-95
19. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal Biochem 72 (1976) 245-254
20. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95 (1979) 351-358
21. Sassa S. δ-Aminolevulinic acid dehydratase assay. Enzyme 28 (1982) 133-145
22. Hegesh E., Gruener N., Cohen S., et al. A sensitive micromethod for the determination of methemoglobin in blood. Clin Chim Acta 30 (1970) 679-682
23. Gonçalves T.L., Erthal F., Corte C.L., et al. Involvement of oxidative stress in the pre-malignant and malignant states of cervical cancer in women. Clin Biochem 38 (2005) 1071-1075
24. Vento M., Asensi M., Sastre J., et al. Hyperoxemia caused by resuscitation with pure oxygen may alter intracellular redox status by increasing oxidized glutathione in asphyxiated newly born infants. Semin Perinatol 26 (2002) 406-410
25. Moreira P.I., Siedlak S.L., Aliev G., et al. Oxidative stress mechanisms and potential therapeutics in Alzheimer disease. Neural Transm 112 (2005) 921-932
26. Haest C.W.M., Kamp D., and Deuticke B. Formation of disulfide bonds between glutathione and membrane SH groups in human erythrocytes. Biochim Biophys Acta 557 (1979) 363-371
27. Mills B.J., and Lang C.A. Differential distribution of free and bound glutathione and cyst(e)ine in human blood. Biochem Pharmacol 52 (1996) 401-406
28. Kunh W., Roebroek R., Blom H., et al. Elevated plasma levels of homocysteine in Parkinson's disease. Eur Neurol 40 (1998) 225-227
29. Mattson M.P., Kruman I., and Duan W. Folic acid and homocysteine in age-related disease. Ageing Res Rev 1 (2002) 95-111
30. Morris M.S. Homocysteine and Alzheimer's disease. Lancet Neurol 2 (2003) 425-428
31. Dwyer B.E., Raina A.K., Perry G., et al. Homocysteine and Alzheimer's disease: a modifiable risk?. Free Radic Biol Med 36 (2004) 1471-1475
32. Yoo J.H., Chung C.S., and Kang S.S. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. Stroke 29 (1998) 2478-2483.
33. Eikelboom J.W., Hankey G.J., Anand S.S., et al. Association between high homo-cyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 31 (2000) 1069-1075
34. Billion S., Tribout B., Cadet E., et al. Hyperhomocysteinemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12. Nephrol Dial Transplant 17 (2002) 455-461.
35. Abdel-Raheem M.M., Hebert B., Potti A., et al. Hyperhomocysteinemia and the risk of thromboembolic phenomenon in patients with chronic renal failure. Thromb Res 105 (2002) 299-302
36. Darvesh S., Walsh R., and Martin E. Homocysteine thiolactone and human cholinesterases. Cell Mol Neurobiol 27 1 (2007) 33-48
37. Calderon-Margalit R., Adler B., Abramson J.H., et al. Butyrylcholinesterase activity, cardiovascular risk factors and mortality in middle-aged elderly men and women in Jerusalem. Clin Chem 52 5 (2006) 845-852.
38. Alcantara V.M., Chautard-Freire-Maia E.A., Scartezini M., et al. Butyrylcholinesterase activity and risk factors for coronary artery disease. Scand J Clin Lab Invest 62 (2002) 399-404
39. Siesjo B.K., Agardh C.D., and Bengtsson F. Free radicals and brain damage. Brain Metab Rev 1 (1989) 165-211
40. Kern P.A., Fishman R.B., Song W., et al. The effect of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) on oxidative enzymes in adipocytes and liver. Toxicology 171 (2002) 117-125
41. +, ATPase activity in parietal, prefrontal and cingulated cortex of young rats. Int J Dev Neurosci 22 (2004) 185-190
42. +, ATPase activity in hippocampus of rats subjected to chemically induced hyperhomocysteinemia. Neurochem Res 27 (2002) 1593-1598
43. Streck E.L., Delwing D., Tagliari B., et al. Brain energy metabolism is compromised by the metabolites accumulating in homocystinuria. Neurochem Int 43 (2003) 597-602
44. Scherer B.S., Stefanello F.M., Mattos C., et al. . Homocysteine reduces cholinesterase activity in rat and human serum. Int J Devl Neurosci 25 (2007) 201-205
45. Schallreuter K.U., Gibbons N.C., Elwary S.M., et al. Calcium-activated butyrylcholinesterase in human skin protects acetylcholinesterase against suicide inhibition by neurotoxic organophosphates. Biochem Biophys Res Commun 355 (2007) 1069-1074
46. 2: more evidence for oxidative stress in vitiligo. Biochem Biophys Res Commun 349 (2006) 931-938
47. Schallreuter K.U., and Elwary S. Hydrogen peroxide regulates the cholinergic signal in a concentration dependent manner. Life Sci 80 (2007) 2221-2226
48. Zhou J.F., Zhou W., Zhang S.M., et al. Oxidative stress and free radical damage in patients with acute dipterex poisoning. Biomed Environ Sci 17 (2004) 223-233
49. Valentini J., Schmitt G.C., Grotto D., et al. Human erythrocyte δ-aminolevulinate dehydratase activity and oxidative stress in haemodialysis patients. Clin Biochem 40 (2007) 591-594
50. Buchet J.P., Lauwerys R., Hassoun A., et al. Effect of aluminum on porphyrin metabolism in hemodialyzed patients. Nephron 46 (1987) 360-363
51. Kark J.D., Selhub J., Adler B., et al. Nonfasting plasma total homocysteine and mortality in middle-aged and elderly men and women in Jerusalem. Ann Intern Med 131 (1999) 321-330
52. Yoo J.H., Chung C.S., and Kang S.S. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. Stroke 29 (1998) 2478-2483
53. Fowler B. Disorders of homocysteine metabolism. J Inherit Metab Dis 20 (1997) 270-285
54. Eikelboom J.W., Hankey G.J., Anand S.S., et al. Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Stroke 31 (2000) 1069-1075
55. Kark J.D., Selhub J., Adler B., et al. Nonfasting plasma total homocysteine and mortality in middle-aged and elderly men and women in Jerusalem. Ann Intern Med 131 (1999) 321-330